Tinidazole (Tindamax) - A New Anti-Protozoal Drug
Tinidazole (Tindamax - Presutti Labs), an oral antiprotozoal drug similar to metronidazole (Flagyl, and others), has been approved by the FDA for treatment of trichomoniasis in adults and for treatment of giardiasis, intestinal amebiasis and amebic liver abcess in adults and children more than 3 years old. Tinidazole has been widely used outside of the US for decades under the trade name Fasigyn (Pfizer)....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Tinidazole (Tindamax) - A New Anti-Protozoal Drug
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1190
Article Code: 1190b
Date: August 30, 2004
Volume: 46
Pages: 70-72
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1190
Article Code: 1190b
Date: August 30, 2004
Volume: 46
Pages: 70-72
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)